Patents by Inventor Nathalie Lambert

Nathalie Lambert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11460467
    Abstract: The present invention relates to an in vitro method for diagnosing lupus in a subject, said method comprising the step of detecting in a biological sample obtained from the subject the autoantibody recognizing the protein biomarker THEX1. More, the invention relates to kits and array useful for carrying out diagnosis methods according to the present invention.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: October 4, 2022
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), Université d'Aix Marseille, GFRS (Groupe Francophone de Recherche sur la Sclerodermie Systemique)
    Inventors: Nathalie Lambert, Fanny Arnoux, Doua Azzouz
  • Publication number: 20190195871
    Abstract: The present invention relates to an in vitro method for diagnosing lupus in a subject, said method comprising the step of detecting in a biological sample obtained from the subject the autoantibody recognizing the protein biomarker THEX1. More, the invention relates to kits and array useful for carrying out diagnosis methods according to the present invention.
    Type: Application
    Filed: February 7, 2019
    Publication date: June 27, 2019
    Inventors: Nathalie Lambert, Fanny Arnoux, Doua Azzouz
  • Publication number: 20170074876
    Abstract: The present invention relates to an in vitro method for diagnosing lupus in a subject, said method comprising the step of detecting in a biological sample obtained from the subject the autoantibody recognizing the protein biomarker THEX1. More, the invention relates to kits and array useful for carrying out diagnosis methods according to the present invention.
    Type: Application
    Filed: March 12, 2015
    Publication date: March 16, 2017
    Inventors: Nathalie Lambert, Fanny Arnoux, Doua Azzouz
  • Publication number: 20150185226
    Abstract: The present invention relates to an in vitro method for diagnosing scleroderma in a subject, said method comprising the step of detecting in a biological sample obtained from the subject one or more autoantibodies recognizing one or more protein biomarkers selected from the group of proteins consisting of THEX1, AIF1, FGF2, EphB2, CLK1 and ANKS6.
    Type: Application
    Filed: July 23, 2013
    Publication date: July 2, 2015
    Inventors: Nathalie Lambert, Isabelle Auger, Jean Roudier